Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.65 USD | -1.49% | +9.50% | +107.03% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+107.03% | 173M | |
-1.43% | 104B | |
+8.96% | 105B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- RGLS Stock
- News Regulus Therapeutics Inc.
- Regulus Therapeutics Says Kidney Disease Drug Showed Favorable Safety Profile in Phase 1 Study